HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance
Biotech psychedelics company HAVN Life Sciences Inc. (OTC:HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean ("ABO"), previously announced on July 2
Benzinga Real-time NewsAug 19, 2022 16:06 ET
HAVN Life Sciences announces 1-for-30 reverse stock split
HAVN Life Sciences (OTCPK:HAVLF) announced Friday the reverse stock split at 1-for-30 of its shares. Stock will begin trading on a consolidated basis on August 3, 2022, with a new CUSIP number. As
Seeking AlphaJul 29, 2022 17:01 ET
HAVN Life Announces a 30:1 Consolidation of its Common Shares
VANCOUVER, British Columbia, July 29, 2022 (GLOBE NEWSWIRE) -- HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardize
GlobeNewswireJul 29, 2022 16:35 ET
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC:HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its the
Benzinga Real-time NewsJun 28, 2022 15:30 ET
HAVN Life enters supply agreement with MPB Group
HAVN Life Sciences (OTCPK:HAVLF) enters into a supply partnership with a comprehensive outpatient mental health clinic, MPB Group. MPB Group is partnered with Healing Escapes Foundation retreats, a n
Seeking AlphaJun 28, 2022 07:39 ET
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
VANCOUVER, BC / ACCESSWIRE / April 30, 2022 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE:5NP), a biotechnology company pursuing standardized extraction of psychedelic compounds for investigat
AccesswireApr 30, 2022 08:05 ET
HAVN Life expands supply agreement with Mycotopia Therapies
HAVN Life Sciences (OTCPK:HAVLF) has expanded its supply partnership with Mycotopia Therapies, adding a second supply agreement that covers functional mushrooms, HAVN Life's recently launched natural
Seeking AlphaMar 22, 2022 09:14 ET
HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market
HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE: 5NP), a biotechnology company working with psychedelic compounds for investigational research to support brain health and cognitive function, annou
Benzinga Real-time NewsFeb 10, 2022 22:06 ET
Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
Biotech company Havn Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) is purchasing functional mushroom wellness brand Spore Life Sciences Inc. The Deal Details Under the deal between HAVN Life, its newly i
Benzinga Real-time NewsDec 20, 2021 14:06 ET
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will
AccesswireDec 6, 2021 08:36 ET
HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada
Demonstrating the integrity of its supply chain from Jamaica into Canada, biotechnology company HAVN Life Sciences (OTCPK: HAVLF) achieved a milestone with international delivery - not an easy task. M
Benzinga Real-time NewsNov 23, 2021 14:26 ET
Press Release: HAVN Life Announces Departure of Rick Brar as Director
HAVN Life Announces Departure of Rick Brar as Director Canada NewsWire VANCOUVER, BC, Oct. 25, 2021 VANCOUVER, BC, Oct. 25, 2021 /CNW/ - HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF
Dow Jones NewswiresOct 25, 2021 08:12 ET
Havn Life Sciences Offers Update on Operations; Rose 9.3% From Near 52 Week Lows on Friday; Surges 16.5% in Frankfurt Trading
08:48 AM EDT, 10/04/2021 (MT Newswires) -- Havn Life Sciences Inc. (HAVN.CSE), which rose 9.3% from near 52 week lows on Friday, over the weekend said it expects to import the first crop of psilocybi
MT NewswiresOct 4, 2021 08:50 ET
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
The partnership is a integral step in the The Company's path to market in the U.S., achieving one of its most important milestones to-dateVANCOUVER, BC / ACCESSWIRE / September 23, 2021 / Havn Life Sc
AccesswireSep 22, 2021 21:30 ET
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
VANCOUVER, BC / ACCESSWIRE / September 21, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company pursuing standardized extraction o
AccesswireSep 20, 2021 20:00 ET
No Data
No Data